Health Diagnostic Startups Raised Record $4.8B In 2020
Capital Planning Valuation Strategy™
Health Diagnostic Startups Raised Record $4.8B In 2020
Many of the diagnostic companies we talk to tell us how much harder it is for diagnostics to get funded than therapeutics. We won’t judge “harder” or not, but there’s certainly no shortage of funding for diagnostic startups—they raised a record $4.8B in 2020.
And while Covid-19 testing may not be the boom opportunity it was a year ago, there’s still a tremendous need worldwide. More importantly, the awareness of the need for rapid pandemic response, plus the development of new technologies that can be generalized to other diseases, means a potential boom for diagnostics post-pandemic.
The money’s out there.
Health Diagnostic Startups Raised Record $4.8B In 2020, See New Opportunities Post-Pandemic
The at-home testing market helped bump the overall health diagnostic sector ahead by five to 10 years.
Health Diagnostic Startups Raised Record $4.8B In 2020
Many of the diagnostic companies we talk to tell us how much harder it is for diagnostics to get funded than therapeutics. We won’t judge “harder” or not, but there’s certainly no shortage of funding for diagnostic startups—they raised a record $4.8B in 2020.
And while Covid-19 testing may not be the boom opportunity it was a year ago, there’s still a tremendous need worldwide. More importantly, the awareness of the need for rapid pandemic response, plus the development of new technologies that can be generalized to other diseases, means a potential boom for diagnostics post-pandemic.
The money’s out there.
Health Diagnostic Startups Raised Record $4.8B In 2020, See New Opportunities Post-Pandemic
The at-home testing market helped bump the overall health diagnostic sector ahead by five to 10 years.